Bank of New York Mellon Corp cut its stake in National HealthCare Co. (NYSE:NHC - Free Report) by 5.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 117,870 shares of the company's stock after selling 6,811 shares during the period. Bank of New York Mellon Corp owned approximately 0.76% of National HealthCare worth $10,938,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Summit Global Investments grew its position in shares of National HealthCare by 1.1% in the first quarter. Summit Global Investments now owns 10,745 shares of the company's stock valued at $997,000 after purchasing an additional 114 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of National HealthCare by 2.3% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,966 shares of the company's stock valued at $964,000 after purchasing an additional 202 shares during the last quarter. Bessemer Group Inc. grew its position in shares of National HealthCare by 396.3% in the fourth quarter. Bessemer Group Inc. now owns 268 shares of the company's stock valued at $29,000 after purchasing an additional 214 shares during the last quarter. RWA Wealth Partners LLC grew its position in shares of National HealthCare by 16.7% in the fourth quarter. RWA Wealth Partners LLC now owns 2,100 shares of the company's stock valued at $226,000 after purchasing an additional 300 shares during the last quarter. Finally, Sei Investments Co. grew its position in shares of National HealthCare by 3.7% in the fourth quarter. Sei Investments Co. now owns 9,618 shares of the company's stock valued at $1,035,000 after purchasing an additional 340 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded shares of National HealthCare from a "buy" rating to a "strong-buy" rating in a research report on Monday, May 12th.
Read Our Latest Stock Analysis on National HealthCare
National HealthCare Trading Down 1.2%
NYSE NHC traded down $1.12 during mid-day trading on Thursday, reaching $94.48. 52,195 shares of the stock were exchanged, compared to its average volume of 60,625. National HealthCare Co. has a 1-year low of $89.14 and a 1-year high of $138.49. The business's fifty day simple moving average is $103.81 and its 200 day simple moving average is $98.68. The stock has a market capitalization of $1.46 billion, a PE ratio of 11.84 and a beta of 0.55. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.77 and a current ratio of 1.80.
National HealthCare Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Monday, June 30th will be given a dividend of $0.64 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $2.56 dividend on an annualized basis and a yield of 2.71%. This is a positive change from National HealthCare's previous quarterly dividend of $0.61. National HealthCare's dividend payout ratio (DPR) is 36.99%.
National HealthCare Company Profile
(
Free Report)
National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Featured Articles

Before you consider National HealthCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National HealthCare wasn't on the list.
While National HealthCare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.